Outcome of a public consultation on the draft risk assessment of perfluoroalkyl substances in food

No abstract is available for this paper.

• Publication year

  2020

• Venue

  EFSA Supporting Publications

• Publication date

  2020-09-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.2903/sp.efsa.2020.en-1931
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Associations of exposure to perfluoroalkyl substances with thyroid hormone concentrations and birth size.

  2020cited by this paper
• Associations between perfluoroalkyl substances and serum lipids in a Swedish adult population with contaminated drinking water

  2020cited by this paper
• Associations of Perfluoroalkyl substances with blood lipids and Apolipoproteins in lipoprotein subspecies: the POUNDS-lost study

  2020cited by this paper
• Serum Levels of Perfluoroalkyl Substances (PFAS) in Adolescents and Young Adults Exposed to Contaminated Drinking Water in the Veneto Region, Italy: A Cross-Sectional Study Based on a Health Surveillance Program

  2020cited by this paper
• Health Impacts of Developmental Exposure to Environmental Chemicals

  2020cited by this paper
• Perfluorooctanoic acid alters progesterone activity in human endometrial cells and induces reproductive alterations in young women.

  2020cited by this paper
• Evaluation of Maternal, Embryo, and Placental Effects in CD-1 Mice following Gestational Exposure to Perfluorooctanoic Acid (PFOA) or Hexafluoropropylene Oxide Dimer Acid (HFPO-DA or GenX)

  2020cited by this paper
• Transplacental Transfer of Per- and Polyfluoroalkyl Substances Identified in Paired Maternal and Cord Sera Using Suspect and Non-Target Screening.

  2020cited by this paper
• Internal exposure to perfluoroalkyl substances (PFASs) and biological markers in 101 healthy 1-year-old children: associations between levels of perfluorooctanoic acid (PFOA) and vaccine response

  2020cited by this paper
• Prenatal exposure to perfluoroalkyl substances, immune-related outcomes, and lung function in children from a Spanish birth cohort study.

  2019cited by this paper
• A mortality study on male subjects exposed to polyfluoroalkyl acids with high internal dose of perfluorooctanoic acid.

  2019cited by this paper
• A transgenerational toxicokinetic model and its use in derivation of Minnesota PFOA water guidance

  2019cited by this paper
• Guideline levels for PFOA and PFOS in drinking water: the role of scientific uncertainty, risk assessment decisions, and social factors

  2019cited by this paper
• Dose Effects of Ammonium Perfluorooctanoate on Lipoprotein Metabolism in APOE*3-Leiden.CETP Mice

  2019cited by this paper
• Maternal levels of perfluoroalkyl substances (PFASs) during pregnancy and childhood allergy and asthma related outcomes and infections in the Norwegian Mother and Child (MoBa) cohort.

  2019cited by this paper
• Serum concentrations of PFASs and exposure-related behaviors in African American and non-Hispanic white women

  2019cited by this paper
• Perfluorohexanoic acid toxicity, part I: Development of a chronic human health toxicity value for use in risk assessment

  2019cited by this paper
• Water and soil pollution as determinant of water and food quality/contamination and its impact on male fertility

  2019cited by this paper
• Concentrations of perfluoroalkyl substances (PFASs) in human embryonic and fetal organs from first, second, and third trimester pregnancies.

  2019cited by this paper
• Guidance on harmonised methodologies for human health, animal health and ecological risk assessment of combined exposure to multiple chemicals

  2019cited by this paper
• Perfluoro-octanoic acid impairs sperm motility through the alteration of plasma membrane

  2019cited by this paper
• Prenatal Exposure to Per- and Polyfluoroalkyl Substances (PFASs) and Association between the Placental Transfer Efficiencies and Dissociation Constant of Serum Proteins-PFAS Complexes.

  2019cited by this paper
• Prenatal perfluorooctanoic acid exposure is associated with early onset atopic dermatitis in 5-year-old children.

  2019cited by this paper
• Perfluoroalkyl substances, airways infections, allergy and asthma related health outcomes - implications of gender, exposure period and study design.

  2019cited by this paper
• Bayesian evaluation of a physiologically based pharmacokinetic (PBPK) model for perfluorooctane sulfonate (PFOS) to characterize the interspecies uncertainty between mice, rats, monkeys, and humans: Development and performance verification.

  2019cited by this paper
• Physico-chemical properties and gestational diabetes predict transplacental transfer and partitioning of perfluoroalkyl substances.

  2019cited by this paper
• Associations between longitudinal serum perfluoroalkyl substance (PFAS) levels and measures of thyroid hormone, kidney function, and body mass index in the Fernald Community Cohort.

  2018cited by this paper
• Concentrations of perfluoroalkyl substances and bisphenol A in newborn dried blood spots and the association with child behavior.

  2018cited by this paper
• Serum polyfluoroalkyl chemicals are associated with risk of cardiovascular diseases in national US population.

  2018cited by this paper
• Per- and polyfluoroalkyl substances and fluorinated alternatives in urine and serum by on-line solid phase extraction-liquid chromatography-tandem mass spectrometry.

  2018cited by this paper
• Perfluorinated compounds in food simulants after migration from fluorocarbon resin-coated frying pans, baking utensils, and non-stick baking papers on the Korean market

  2018cited by this paper
• Endocrine disruptors and neonatal anthropometry, NICHD Fetal Growth Studies - Singletons.

  2018cited by this paper
• Serum Perfluorooctanoic Acid and Birthweight: An Updated Meta-analysis With Bias Analysis

  2018cited by this paper
• Prenatal Exposure to Perfluoroalkyl Substances and Birth Outcomes; An Updated Analysis from the Danish National Birth Cohort

  2018cited by this paper
• Concentrations of endocrine disrupting chemicals in newborn blood spots and infant outcomes in the upstate KIDS study.

  2018cited by this paper
• Development of Policy Relevant Human Biomonitoring Indicators for Chemical Exposure in the European Population

  2018cited by this paper
• Alteration of Bile Acid and Cholesterol Biosynthesis and Transport by Perfluorononanoic Acid (PFNA) in Mice

  2018cited by this paper
• Plasma Concentrations of Perfluoroalkyl Substances and Risk of Type 2 Diabetes: A Prospective Investigation among U.S. Women

  2018cited by this paper
• Perfluorooctane sulfonate exacerbates mast cell-mediated allergic inflammation by the release of histamine

  2018cited by this paper
• Ableitung von HBM-I-Werten für Perfluoroktansäure (PFOA) und Perfluoroktansulfonsäure (PFOS) – Stellungnahme der Kommission „Humanbiomonitoring“ des Umweltbundesamts

  2018cited by this paper
• Prenatal exposure to perfluoralkyl substances (PFASs) associated with respiratory tract infections but not allergy‐ and asthma‐related health outcomes in childhood

  2018cited by this paper
• Perfluoroalkyl substances in adolescents in northern Norway: Lifestyle and dietary predictors. The Tromsø study, Fit Futures 1.

  2018cited by this paper
• Biomonitoring of perfluorinated compounds in adults exposed to contaminated drinking water in the Veneto Region, Italy.

  2018cited by this paper
• Maternal Plasma Concentrations of Per- and Polyfluoroalkyl Substances and Breastfeeding Duration in the Norwegian Mother and Child Cohort

  2018cited by this paper
• Perfluorohexane Sulfonate (PFHxS) and a Mixture of Endocrine Disrupters Reduce Thyroxine Levels and Cause Antiandrogenic Effects in Rats

  2018cited by this paper
• Application of benchmark analysis for mixed contaminant exposures: Mutual adjustment of perfluoroalkylate substances associated with immunotoxicity

  2018cited by this paper
• Reproductive and developmental toxicity of potassium perfluorohexanesulfonate in CD-1 mice.

  2018cited by this paper
• What is the effect of phasing out long-chain per- and polyfluoroalkyl substances on the concentrations of perfluoroalkyl acids and their precursors in the environment? A systematic review

  2018cited by this paper
• Perfluoroalkyl substances and changes in body weight and resting metabolic rate in response to weight-loss diets: A prospective study

  2018cited by this paper
• Stochastic Pharmacokinetic-Pharmacodynamic Modeling for Assessing the Systemic Health Risk of Perfluorooctanoate (PFOA)

  2018cited by this paper
• Guidance on Uncertainty Analysis in Scientific Assessments

  2018cited by this paper
• Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food

  2018cited by this paper
• Exposure to per- and polyfluoroalkyl substances leads to immunotoxicity: Epidemiological and toxicological evidence

  2018cited by this paper
• Exploring sex differences in human health risk assessment for PFNA and PFDA using a PBPK model

  2018cited by this paper
• Cord‐serum per‐ and poly‐fluoroalkyl substances and atopy and eczema at 12‐months

  2018cited by this paper
• Endocrine Disruption of Androgenic Activity by Perfluoroalkyl Substances: Clinical and Experimental Evidence

  2018cited by this paper
• Screening and identification of per- and polyfluoroalkyl substances in microwave popcorn bags.

  2017cited by this paper
• Exposure to perfluoroalkyl substances and thyroid function in pregnant women and children: A systematic review of epidemiologic studies.

  2017cited by this paper
• Evaluation of Serum Lipid, Thyroid, and Hepatic Clinical Chemistries in Association With Serum Perfluorooctanesulfonate (PFOS) in Cynomolgus Monkeys After Oral Dosing With Potassium PFOS

  2017cited by this paper
• Exposure to PFOA and PFOS and fetal growth: a critical merging of toxicological and epidemiological data

  2017cited by this paper
• Update: use of the benchmark dose approach in risk assessment

  2017cited by this paper
• Fluorinated Compounds in U.S. Fast Food Packaging.

  2017cited by this paper
• Sex-specific risk assessment of PFHxS using a physiologically based pharmacokinetic model

  2017cited by this paper
• Prenatal exposure to perfluoroalkyl acids and prevalence of infectious diseases up to 4years of age.

  2017cited by this paper
• Exposure of Pregnant Mice to Perfluorobutanesulfonate Causes Hypothyroxinemia and Developmental Abnormalities in Female Offspring

  2017cited by this paper
• Estimated exposures to perfluorinated compounds in infancy predict attenuated vaccine antibody concentrations at age 5-years

  2017cited by this paper
• Shorter duration of breastfeeding at elevated exposures to perfluoroalkyl substances.

  2017cited by this paper
• Maternal serum perfluoroalkyl substances during pregnancy and duration of breastfeeding.

  2016cited by this paper
• Association between prenatal exposure to perfluorinated compounds and symptoms of infections at age 1-4years among 359 children in the Odense Child Cohort.

  2016cited by this paper
• Ubiquitous Occurrence of Fluorotelomer Alcohols in Eco-Friendly Paper-Made Food-Contact Materials and Their Implication for Human Exposure.

  2016cited by this paper
• Fortschreibung der vorläufigen Bewertung von per- und polyfluorierten Chemikalien (PFC) im Trinkwasser

  2016cited by this paper
• Exposure to Thyroid-Disrupting Chemicals: A Transatlantic Call for Action

  2016cited by this paper
• Antibody response to booster vaccination with tetanus and diphtheria in adults exposed to perfluorinated alkylates

  2016cited by this paper
• Prenatal exposure to environmental chemical contaminants and asthma and eczema in school‐age children

  2015cited by this paper
• Perfluoroalkyl Acid Concentrations in Blood Samples Subjected to Transportation and Processing Delay

  2015cited by this paper
• Breastfeeding as an Exposure Pathway for Perfluorinated Alkylates.

  2015cited by this paper
• Associations of Perfluoroalkyl Substances (PFAS) with Lower Birth Weight: An Evaluation of Potential Confounding by Glomerular Filtration Rate Using a Physiologically Based Pharmacokinetic Model (PBPK)

  2015cited by this paper
• A Birth Cohort Study of Maternal and Infant Serum PCB-153 and DDE Concentrations and Responses to Infant Tuberculosis Vaccination

  2015cited by this paper
• The Navigation Guide—Evidence-Based Medicine Meets Environmental Health: Systematic Review of Human Evidence for PFOA Effects on Fetal Growth

  2014cited by this paper
• Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate.

  2014cited by this paper
• Prenatal exposure to perfluoroalkyl acids and allergic diseases in early childhood.

  2014cited by this paper
• Dietary exposure to selected perfluoroalkyl acids (PFAAs) in four European regions

  2013cited by this paper
• Perfluorooctanoic Acid (PFOA) Exposures and Incident Cancers among Adults Living Near a Chemical Plant

  2013cited by this paper
• Migration of perfluoroalkyl acids from food packaging to food simulants

  2013cited by this paper
• Associations between PFOA, PFOS and changes in the expression of genes involved in cholesterol metabolism in humans.

  2013cited by this paper
• Immunotoxicity of perfluorinated alkylates: calculation of benchmark doses based on serum concentrations in children

  2013cited by this paper
• A species difference in the peroxisome proliferator-activated receptor α-dependent response to the developmental effects of perfluorooctanoic acid.

  2013cited by this paper
• Pitfalls in the measurement and interpretation of thyroid function tests☆

  2013cited by this paper
• Perfluoroalkyl substances in human milk: a first survey in Italy.

  2013cited by this paper
• Development of Pbpk Models for Pfoa and Pfos for Human Pregnancy and Lactation Life Stages

  2013cited by this paper
• Occurrence of selected perfluorinated alkyl acids in lunch meals served at school canteens in Italy and their relevance for children’s intake

  2013cited by this paper
• Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood

  2013cited by this paper
• Prenatal exposure to polychlorinated biphenyls and dioxins from the maternal diet may be associated with immunosuppressive effects that persist into early childhood.

  2013cited by this paper
• Trends in the analysis of persistent organic pollutants (POPs) in human blood

  2013cited by this paper
• Comment on "associations between PFOA, PFOS and changes in the expression of genes involved in cholesterol metabolism in humans" by Fletcher et al., Environment International 57-58 (2013) 2-10.

  2013cited by this paper
• Chronic dietary toxicity and carcinogenicity study with potassium perfluorooctanesulfonate in Sprague Dawley rats.

  2012cited by this paper
• Prenatal exposure to perfluorinated chemicals and relationship with allergies and infectious diseases in infants.

  2012cited by this paper
• Serum vaccine antibody concentrations in children exposed to perfluorinated compounds.

  2012cited by this paper
• Comparison and evaluation of pharmacokinetics of PFOA and PFOS in the adult rat using a physiologically based pharmacokinetic model.

  2012cited by this paper
• Effect of maternal obesity on estrous cyclicity, embryo development and blastocyst gene expression in a mouse model.

  2012cited by this paper

• Age disparities in PFAS-associated influenza-like illness among adult females at low exposure levels.

  2026cites this paper
• Risk Assessment of Chemical Mixtures in Foods: A Comprehensive Methodological and Regulatory Review

  2026influential citation
• Microplastics: Detection methods-An update

  2025cites this paper
• Per- and polyfluoroalkyl Substances (PFAS) in Market Meats from Guangzhou, China: Age-Specific Dietary Exposure and Threshold Exceedance Risks.

  2025cites this paper
• Development of a qualitative risk assessment for meat from wild boar from a One‐Health perspective

  2025influential citation
• Ubiquitous global use of persistent PFAS threatens Arctic Indigenous peoples for decades to come

  2025cites this paper
• Adverse health effects of exposure to plastic, microplastics and their additives: environmental, legal and policy implications for Israel

  2024influential citation
• Associations between serum perfluoroalkyl and polyfluoroalkyl concentrations and diabetes mellitus in the Korean general population: Insights from the Korean National Environmental Health Survey 2018-2020.

  2024cites this paper
• Transcriptomic and metabolomic profile changes in the liver of Sprague Dawley rat offspring after maternal PFOS exposure during gestation and lactation.

  2023cites this paper
• Weight of evidence evaluation for chemical-induced immunotoxicity for PFOA and PFOS: findings from an independent panel of experts

  2023cites this paper
• Assessment of exposure to perfluorinated industrial substances and risk of immune suppression in Greenland and its global context: a mixed-methods study.

  2023cites this paper
• Benchmark dose calculations for PFAS exposure based on two data sets on immunotoxic effects

  2023cites this paper
• Per- and Polyfluoroalkyl Substances Concentrations are Associated with an Unfavorable Cardio-Metabolic Risk Profile: Findings from Two Population-Based Cohort Studies

  2023cites this paper
• Quantitative Analysis of PFAS in Milk, Infant Formula, and Related Ingredients Using Liquid Chromatography–Tandem Mass Spectrometry

  2022cites this paper
• Per- and polyfluoroalkyl substances and incident diabetes in midlife women: the Study of Women’s Health Across the Nation (SWAN)

  2022cites this paper
• Quantitative Analysis of PFAS in Milk, Infant Formula, and Related Ingredients Using LC–MS

  2022cites this paper
• PFAS in food: BfR confirms critical exposure to industrial chemicals-BfR Opinion No 020/2021 issued 28 June, 2021

  2021cites this paper
• Resources and Risks: Perceptions on the Application of Sewage Sludge on Agricultural Land in Sweden, a Case Study

  2021cites this paper
• Food safety and sanitation challenges of public university students in a developing country

  2021cites this paper
• How to Address Consumers’ Concerns and Information Needs about Emerging Chemical and Microbial Contaminants in Drinking Water; The Case of GenX in The Netherlands

  2021cites this paper
• Perfluoroalkyl substances exposure and immunity, allergic response, infection, and asthma in children: review of epidemiologic studies

  2021cites this paper
• Risk to human health related to the presence of perfluoroalkyl substances in food

  2020cites this paper